KVA12123,Pembrolizumab
kineta bio,Merck
['biomarker', 'kva12123']
$ka kineta unveils new vista biomarker data and kva12123 phase 1/2 clinical trial update at aacr annual meeting 2023 #clinicaltrial #trading #investing
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i